|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
7.875 +0.010 (+0.127%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 417,104 | -14.457% | 1,045,766 | 805,857 | 1,208,524 | 1,201,604 |
| Cost of Sales | (147,786) | -7.906% | -- | -- | -- | -- |
| Gross Profit | 269,318 | -17.671% | -- | -- | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,215) | -90.823% | (38,198) | (28,529) | (15,412) | (20,777) | |
| Profit / (Loss) on Disposal | -- | -- | 4 | 39 | 4 | 25 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 133,457 | 4.826% | 301,712 | 131,599 | 305,906 | 336,880 | |
| Taxation | (13,518) | 5.353% | (29,087) | (6,938) | (28,088) | (29,161) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 18 | -- | (83) | 327 | 6 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 119,957 | 4.794% | 272,542 | 124,988 | 277,824 | 307,719 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,404 | -- | (11,396) | (17,068) | (16,582) | (20,175) |
| Depreciation & Amortisation | 21,026 | 5.068% | 41,804 | 37,677 | 34,655 | 30,162 |
| Directors' Emoluments | -- | -- | 3,645 | 3,197 | 3,938 | 3,780 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 31.000 | 3.333% | 71.000 | 33.000 | 72.000 | 80.000 |
| DPS (cts) | 13.000 | -- | 36.000 | 13.200 | 36.200 | 31.300 |
| Dividend Payout Ratio (%) | 41.935% | -- | 50.704% | 40.000% | 50.278% | 39.125% |
| Cash flow per share ($) | -- | -- | 1.055 | (0.005) | 1.334 | 0.107 |
| NBV per share ($) | 7.975 | -- | 7.811 | 7.368 | 7.502 | 7.077 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 119,957 |
| %Change | 4.794% |
| EPS / (LPS) | RMB 0.310 |
| NBV Per Share (¥) | RMB 7.975 |